Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 33.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 67.60
  • 52 Week Low: 13.00
  • Currency: UK Pounds
  • Shares Issued: 287.15m
  • Volume: 13,200
  • Market Cap: £95.91m
  • RiskGrade: 479

Futura enters erection gel licensing deal with M8

By Josh White

Date: Tuesday 31 Aug 2021

LONDON (ShareCast) - (Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.
The AIM-traded firm said it would receive payments on all sales of MED3000 from M8, and would also be eligible to receive up to $8.5m in milestone payments based on deliverable sales volumes, including a small initial upfront payment.

M8 would be responsible for all local MED3000 development and regulatory costs in Brazil and Mexico, as well as marketing expenses and ongoing pharmacovigilance and safety within the region.

Futura described M8 as a specialty biopharmaceutical company based and incorporated in the United States, focussed on licensing, marketing and distributing "innovative and established" therapeutics in the two largest Latin American markets, Brazil and Mexico.

"We are excited to be entering into this agreement with m8 to expand MED3000's market reach to Brazil and Mexico, both significant markets for ED," said chief executive officer James Barder.

"We are very pleased to have a partner with m8's dedicated launch, brand-building and marketing experience as well as resources and strong pharmaceutical connections in Latin America.

"We look forward to working closely with their team."

At 1442 BST, shares in Futura Medical were up 2.8% at 39.17p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 33.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 67.60
52 Week Low 13.00
Volume 13,200
Shares Issued 287.15m
Market Cap £95.91m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.69% below the market average52.69% below the market average52.69% below the market average52.69% below the market average52.69% below the market average
55.1% below the sector average55.1% below the sector average55.1% below the sector average55.1% below the sector average55.1% below the sector average
Price Trend
19.75% above the market average19.75% above the market average19.75% above the market average19.75% above the market average19.75% above the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 01-Dec-2021

Time Volume / Share Price
12:01 602 @ 33.41p
10:40 9,000 @ 32.77p
08:59 3,247 @ 33.50p
08:28 99 @ 33.54p
08:02 91 @ 33.41p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page